{"version":"1.0","provider_name":"Campus Biotech","provider_url":"https:\/\/campusbiotech.ch\/fr\/","title":"Traiter autrement la schizophr\u00e9nie : l\u2019approche de Neurosterix - Campus Biotech","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"oWsQzaKHW5\"><a href=\"https:\/\/campusbiotech.ch\/fr\/traiter-autrement-la-schizophrenie-lapproche-de-neurosterix\/\">Traiter autrement la schizophr\u00e9nie : l\u2019approche de Neurosterix<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/campusbiotech.ch\/fr\/traiter-autrement-la-schizophrenie-lapproche-de-neurosterix\/embed\/#?secret=oWsQzaKHW5\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Traiter autrement la schizophr\u00e9nie : l\u2019approche de Neurosterix\u00a0\u00bb &#8212; Campus Biotech\" data-secret=\"oWsQzaKHW5\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/campusbiotech.ch\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/campusbiotech.ch\/wp-content\/uploads\/2026\/05\/DSC00477-e1777988594234.jpg","thumbnail_width":7008,"thumbnail_height":2990,"description":"Neurosterix d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de th\u00e9rapies qui cible les m\u00e9canismes c\u00e9r\u00e9braux impliqu\u00e9s dans les troubles neuropsychiatriques. Son programme le plus avanc\u00e9, actuellement en phase clinique, explore une approche innovante pour le traitement de la schizophr\u00e9nie. Rencontre avec Dominik Schelshorn, Head of Biology chez Neurosterix. \u00a0 1. Qu\u2019est-ce qui distingue l\u2019approche scientifique de Neurosterix des [&hellip;]"}